down arrow

OncoZenge AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015504097
SEK
6.47
0.38 (6.24%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
NextCell Pharma AB
OncoZenge AB
Sprint Bioscience AB
Ascelia Pharma AB
Dicot AB
Isofol Medical AB
Cessatech A/S
Dextech Medical AB
Alzinova AB
Respiratorius AB
Scandion Oncology A/S
Why is OncoZenge AB ?
1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 42.35%, its profits have risen by 42.1%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is OncoZenge AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
OncoZenge AB
42.35%
-0.39
92.47%
OMX Stockholm 30
8.01%
0.44
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
38.79%
EBIT Growth (5y)
-53.23%
EBIT to Interest (avg)
-12.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.28
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.53
EV to EBIT
-10.20
EV to EBITDA
-10.20
EV to Capital Employed
13.38
EV to Sales
25.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-131.13%
ROE (Latest)
-103.02%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK -8.37 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

NET SALES(9M)

Higher at SEK 2.71 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 1.26%

OPERATING PROFIT(Q)

Highest at SEK 0.04 MM

PRE-TAX PROFIT(Q)

Highest at SEK 0.04 MM

NET PROFIT(Q)

Highest at SEK 0.04 MM

EPS(Q)

Highest at SEK 0

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -12.95 %

Here's what is working for OncoZenge AB
Net Sales
At SEK 2.71 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (SEK MM)

Operating Cash Flow
Highest at SEK -8.37 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Pre-Tax Profit
At SEK 0.04 MM has Grown at 101.85%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 0.04 MM has Grown at 101.85%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (SEK MM)

Operating Profit
Highest at SEK 0.04 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Pre-Tax Profit
Highest at SEK 0.04 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK 0.04 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK 0
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Debtors Turnover Ratio
Highest at 1.26%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Higher at SEK 2.71 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (SEK MM)

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OncoZenge AB
Debt-Equity Ratio
Highest at -12.95 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."